Literature DB >> 21715349

Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability.

Kyle Trudeau1, Sumon Roy, Wen Guo, Cristina Hernández, Marta Villarroel, Rafael Simó, Sayon Roy.   

Abstract

PURPOSE: To determine whether fenofibric acid (FA) reduces high glucose (HG)-induced basement membrane component overexpression and hyperpermeability in human retinal pigment epithelial (RPE) cells.
METHODS: Retinal pigment epithelial cells (ARPE-19) were cultured for 18 days in normal glucose (5 mM) or HG (25 mM) medium and studied for the effects of FA on fibronectin (FN) and collagen IV (Coll IV) expression. During last 3 days of the experiment, 100 μM FA was added to cells grown in HG medium or in HG medium plus IL-1β (HG + IL-1β) to mimic, at least in part, the inflammatory aspect of the diabetic milieu. Real-time RT-PCR was performed to determine FN and Coll IV mRNA levels, whereas protein levels were assessed by Western blot analyses. Cell monolayer morphology and barrier function were analyzed by confocal microscopy using specific antibodies against tight junction proteins, ZO-1, and claudin-1 and by measuring apical-basolateral movements of FITC-dextran, respectively.
RESULTS: FN and Coll IV expression were significantly increased in RPE cells grown in HG or HG + IL-1β medium compared with cells grown in normal medium. When cells grown in HG or HG + IL-1β medium were treated with FA, significant reductions in FN and Coll IV expression were observed. In addition, exposure to FA decreased excess permeability in a dose-dependent manner in cells grown in HG + IL-1β medium. This effect was unrelated to changes in tight junction protein content.
CONCLUSIONS: Findings from this study suggest that the downregulation of basement membrane components by FA may have a protective effect against outer blood-retinal barrier leakage associated with diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715349      PMCID: PMC3175988          DOI: 10.1167/iovs.11-7282

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  40 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Characterization of retinal pigment epithelial cells cultured on microporous filters.

Authors:  C A Heth; M A Yankauckas; M Adamian; R B Edwards
Journal:  Curr Eye Res       Date:  1987-08       Impact factor: 2.424

3.  Preparation of Bruch's membrane and analysis of the age-related changes in the structural collagens.

Authors:  W S Karwatowski; T E Jeffries; V C Duance; J Albon; A J Bailey; D L Easty
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

4.  Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats.

Authors:  S Roy; M Lorenzi
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

5.  Serum inhibits tight junction formation in cultured pigment epithelial cells.

Authors:  C W Chang; L Ye; D M Defoe; R B Caldwell
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-05       Impact factor: 4.799

6.  Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats.

Authors:  Sayon Roy; Tsuyoshi Sato; Gulabray Paryani; Richard Kao
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

7.  Fibronectin of the chorioretinal interface in the monkey: immunohistochemical and immunoelectron microscopic studies.

Authors:  T Ishibashi; T Kohno; N Sorgente; R Patterson; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

8.  Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia.

Authors:  M Guérin; E Bruckert; P J Dolphin; G Turpin; M J Chapman
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-06       Impact factor: 8.311

9.  Ultrastructural aging of the RPE-Bruch's membrane-choriocapillaris complex in the D-galactose-treated mouse.

Authors:  Hisashi Ida; Kazuki Ishibashi; Karen Reiser; Leonard M Hjelmeland; James T Handa
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-07       Impact factor: 4.799

Review 10.  Diabetic retinopathy.

Authors:  Susan Lightman; Hamish M Towler
Journal:  Clin Cornerstone       Date:  2003
View more
  26 in total

1.  Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy.

Authors:  Sumon Roy; Dongjoon Kim; Cristina Hernández; Rafael Simó; Sayon Roy
Journal:  Exp Eye Res       Date:  2015-08-18       Impact factor: 3.467

2.  Oral Monomethyl Fumarate Therapy Ameliorates Retinopathy in a Humanized Mouse Model of Sickle Cell Disease.

Authors:  Wanwisa Promsote; Folami Lamoke Powell; Satyam Veean; Menaka Thounaojam; Shanu Markand; Alan Saul; Diana Gutsaeva; Manuela Bartoli; Sylvia B Smith; Vadivel Ganapathy; Pamela M Martin
Journal:  Antioxid Redox Signal       Date:  2016-08-22       Impact factor: 8.401

Review 3.  Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research.

Authors:  Timothy S Kern; David A Antonetti; Lois E H Smith
Journal:  Ophthalmic Res       Date:  2019-07-30       Impact factor: 2.892

Review 4.  Mechanistic Insights into Pathological Changes in the Diabetic Retina: Implications for Targeting Diabetic Retinopathy.

Authors:  Sayon Roy; Timothy S Kern; Brian Song; Caren Stuebe
Journal:  Am J Pathol       Date:  2016-11-12       Impact factor: 4.307

5.  RPE barrier breakdown in diabetic retinopathy: seeing is believing.

Authors:  Hui-Zhuo Xu; Zhiming Song; Shuhua Fu; Meili Zhu; Yun-Zheng Le
Journal:  J Ocul Biol Dis Infor       Date:  2011-12-31

Review 6.  Is fenofibrate a reasonable treatment for diabetic microvascular disease?

Authors:  Rafael Simó; Olga Simó-Servat; Cristina Hernández
Journal:  Curr Diab Rep       Date:  2015-05       Impact factor: 4.810

7.  Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan.

Authors:  Ying-Chieh Lin; Yu-Ching Chen; Jorng-Tzong Horng; Jui-Ming Chen
Journal:  Medicina (Kaunas)       Date:  2020-07-31       Impact factor: 2.430

Review 8.  Potential new complication in drug therapy development for amyotrophic lateral sclerosis.

Authors:  Svitlana Garbuzova-Davis; Avery Thomson; Crupa Kurien; R Douglas Shytle; Paul R Sanberg
Journal:  Expert Rev Neurother       Date:  2016-07-15       Impact factor: 4.618

Review 9.  Retinal capillary basement membrane thickening: Role in the pathogenesis of diabetic retinopathy.

Authors:  Sayon Roy; Dongjoon Kim
Journal:  Prog Retin Eye Res       Date:  2020-09-18       Impact factor: 21.198

Review 10.  Inflammatory Regulation of CNS Barriers After Traumatic Brain Injury: A Tale Directed by Interleukin-1.

Authors:  Colleen N Bodnar; James B Watson; Emma K Higgins; Ning Quan; Adam D Bachstetter
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.